FDA Approves Libido-Boosting Pill for Menopausal Women
The FDA has expanded the approval of the libido drug Addyi to include women over 65 who are postmenopausal, after initial approval for premenopausal women. Despite past concerns over side effects and modest effectiveness, the drug's approval reflects ongoing efforts to address female sexual health issues.